702
Participants
Start Date
July 1, 2015
Primary Completion Date
February 28, 2024
Study Completion Date
February 28, 2024
Bosutinib
The recommended adult dose of bosutinib is 500 mg orally once daily with food. For newly-diagnosed chronic phase CML, the recommended dose is 400 mg. The dose may be adjusted appropriately according to the patient's condition; however, the maximum dose is 600 mg once daily.
Shibuya-ku
Lead Sponsor
Pfizer
INDUSTRY